The fluticasone propionate/salmeterol HFA MDI is significantly more efficacious in treating asthma than placebo HFA MDI, fluticasone propionate CFC MDI or salmeterol CFC MDI

A Rooklin, D Elkayam,J Weiler, H Windom, L Schoaf, C Scott, KW House,JE Payne,T Shah

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY(2001)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要